Lenalidomide (Teva) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: lenalidomide
Brand name
(ARTG)
: LENALIDOMIDE-TEVA lenalidomide (as hydrochloride monohydrate) 7.5 mg capsule blister packWhat this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide-Teva is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide-Teva is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- Lenalidomide capsules, 7.5 mg mg are hard, non-transparent capsules with black mark 7.5 on white body and with ivory cap.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE-TEVA lenalidomide (as hydrochloride monohydrate) 7.5 mg capsule blister packWhat this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide-Teva is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide-Teva is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- Lenalidomide capsules, 7.5 mg mg are hard, non-transparent capsules with black mark 7.5 on white body and with ivory cap.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE-TEVA lenalidomide (as hydrochloride monohydrate) 7.5 mg capsule blister packWhat this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide-Teva is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide-Teva is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- Lenalidomide capsules, 7.5 mg mg are hard, non-transparent capsules with black mark 7.5 on white body and with ivory cap.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE-TEVA lenalidomide (as hydrochloride monohydrate) 10 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide-Teva is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide-Teva is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- Lenalidomide capsules, 10 mg mg are hard, non-transparent capsules with black mark 10 on ivory body and with green cap.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE-TEVA lenalidomide (as hydrochloride monohydrate) 10 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide-Teva is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide-Teva is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- Lenalidomide capsules, 10 mg mg are hard, non-transparent capsules with black mark 10 on ivory body and with green cap.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE-TEVA lenalidomide (as hydrochloride monohydrate) 10 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide-Teva is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide-Teva is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- Lenalidomide capsules, 10 mg mg are hard, non-transparent capsules with black mark 10 on ivory body and with green cap.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE-TEVA lenalidomide (as hydrochloride monohydrate) 15 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide-Teva is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide-Teva is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- Lenalidomide capsules, 15 mg are hard, non-transparent capsules with black mark 15 on white body and with blue cap.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE-TEVA lenalidomide (as hydrochloride monohydrate) 15 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide-Teva is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide-Teva is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- Lenalidomide capsules, 15 mg are hard, non-transparent capsules with black mark 15 on white body and with blue cap.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE-TEVA lenalidomide (as hydrochloride monohydrate) 15 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide-Teva is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide-Teva is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- Lenalidomide capsules, 15 mg are hard, non-transparent capsules with black mark 15 on white body and with blue cap.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE-TEVA lenalidomide (as hydrochloride monohydrate) 2.5 mg capsule blister packWhat this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide-Teva is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide-Teva is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- Lenalidomide capsules, 2.5 mg are hard, non-transparent capsules with black mark 2.5 on white body and with green cap.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE-TEVA lenalidomide (as hydrochloride monohydrate) 2.5 mg capsule blister packWhat this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide-Teva is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide-Teva is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- Lenalidomide capsules, 2.5 mg are hard, non-transparent capsules with black mark 2.5 on white body and with green cap.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE-TEVA lenalidomide (as hydrochloride monohydrate) 2.5 mg capsule blister packWhat this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide-Teva is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide-Teva is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- Lenalidomide capsules, 2.5 mg are hard, non-transparent capsules with black mark 2.5 on white body and with green cap.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE-TEVA lenalidomide (as hydrochloride monohydrate) 5 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide-Teva is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide-Teva is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- Lenalidomide capsules, 5 mg are hard, non-transparent capsules with black mark 5 on white body and with white cap.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE-TEVA lenalidomide (as hydrochloride monohydrate) 5 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide-Teva is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide-Teva is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- Lenalidomide capsules, 5 mg are hard, non-transparent capsules with black mark 5 on white body and with white cap.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE-TEVA lenalidomide (as hydrochloride monohydrate) 5 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide-Teva is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide-Teva is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- Lenalidomide capsules, 5 mg are hard, non-transparent capsules with black mark 5 on white body and with white cap.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE-TEVA lenalidomide (as hydrochloride monohydrate) 25 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide-Teva is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide-Teva is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- Lenalidomide capsules, 25 mg are hard, non-transparent capsules with black mark 25 on white body and with white cap.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE-TEVA lenalidomide (as hydrochloride monohydrate) 25 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide-Teva is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide-Teva is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- Lenalidomide capsules, 25 mg are hard, non-transparent capsules with black mark 25 on white body and with white cap.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on January, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE-TEVA lenalidomide (as hydrochloride monohydrate) 25 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide-Teva is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide-Teva is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- Lenalidomide capsules, 25 mg are hard, non-transparent capsules with black mark 25 on white body and with white cap.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems